Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.
Flynn Gold Limited has announced a renounceable pro-rata rights issue to raise up to $3 million, partially underwritten by Mahe Capital, to fund exploration drilling across its Tasmanian projects.
